A detailed history of Ameritas Investment Partners, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 1,656 shares of LGND stock, worth $179,543. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,656
Previous 1,656 -0.0%
Holding current value
$179,543
Previous $139,000 18.71%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$58.86 - $72.67 $16,421 - $20,274
279 Added 20.26%
1,656 $99,000
Q2 2023

Aug 11, 2023

BUY
$69.53 - $79.33 $10,985 - $12,534
158 Added 12.96%
1,377 $99,000
Q3 2021

Nov 15, 2021

SELL
$102.33 - $144.73 $467,545 - $661,271
-4,569 Reduced 78.94%
1,219 $170,000
Q1 2021

May 14, 2021

BUY
$99.52 - $215.83 $6,966 - $15,108
70 Added 1.22%
5,788 $882,000
Q4 2020

Feb 12, 2021

SELL
$80.55 - $106.05 $17,640 - $23,224
-219 Reduced 3.69%
5,718 $569,000
Q2 2020

Aug 05, 2020

SELL
$68.28 - $123.65 $13,451 - $24,359
-197 Reduced 3.21%
5,937 $664,000
Q1 2020

May 13, 2020

SELL
$63.37 - $107.88 $19,011 - $32,364
-300 Reduced 4.66%
6,134 $446,000
Q4 2019

Feb 13, 2020

SELL
$96.94 - $113.59 $46,628 - $54,636
-481 Reduced 6.96%
6,434 $671,000
Q3 2019

Nov 14, 2019

SELL
$86.25 - $120.16 $35,103 - $48,905
-407 Reduced 5.56%
6,915 $688,000
Q2 2019

Aug 14, 2019

SELL
$107.38 - $129.34 $43,381 - $52,253
-404 Reduced 5.23%
7,322 $836,000
Q1 2019

May 15, 2019

SELL
$105.93 - $142.47 $31,037 - $41,743
-293 Reduced 3.65%
7,726 $971,000
Q4 2018

Feb 12, 2019

BUY
$128.36 - $272.13 $805,459 - $1.71 Million
6,275 Added 359.81%
8,019 $1.09 Million
Q2 2018

Aug 13, 2018

BUY
$150.77 - $207.98 $1,809 - $2,495
12 Added 0.69%
1,744 $361,000
Q1 2018

May 15, 2018

SELL
$138.63 - $182.62 $9,288 - $12,235
-67 Reduced 3.72%
1,732 $286,000
Q2 2017

Aug 15, 2017

BUY
N/A
1,799
1,799 $218,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.83B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.